911勛圖

The Plasmax Concentrate Advantage

Through a simple��process,��the��Plasmax��System��produces a fully��autologous plasma concentrate��with elevated fibrinogen concentration that is��optimal for haemostasis.1-2

Procedures

  • Autologous Therapies

Philosophies

  • Biologics

Application

  • Multiple

Produces elevated fibrinogen concentration optimal for haemostasis and bone grafting handling.1-2

Fibrinogen concentration

3x

increase.2

System Features

The��Plasmax��Plasma Concentration System is comprised of two distinct parts, the GPS III��Separator and the��Plasmax��Concentrator. The GPS III Separator produces leukocyte-rich platelet-rich plasma (L-PRP) from a small sample of the patient���s own blood. The��Plasmax��Concentrator��produces autologous fibrinogen-rich platelet-poor��plasma concentrate (PPPc)* utilizing polyacrylamide beads to remove excess water.

Features of the system include:

  • Outputs up to 10 cc of rapidly polymerizing autologous plasma concentrate3
  • Outputs up to��3 or 6 cc of PRP, depending on which GPS III kit is being used
  • Produces both outputs in less than 20 minutes
  • Autologous outputs eliminate concern regarding pooled blood sources
*Autologous output from the��Plasmax��Plasma Concentration System eliminates concern regarding pooled blood sources. Pooled plasma sources found in donor-based fibrin sealants carry the risk of transmitting infectious diseases and viruses.

Benefits

Consistent Results

  • Clinically proven GPS technology1

梆鳥梯娶棗措梗莽泭晨硃梗鳥棗莽喧硃莽勳莽

  • Provides between 1.5 and 4 increase in fibrinogen concentration2

Safe

  • A 100% autologous plasma concentrate �����provides��a natural��haemostatic��alternative

Instructions for Use

  • Contains all items needed to process quality plasma concentrate in two minutes

Additional Information